Stemedica Cell Technologies Reports Positive Data in Phase I/I...
SAN DIEGO, Jan. 7, 2019 /PRNewswire-AsiaNet/ -- - itMSCs were safe and well tolerated in the study -- Results of the study are supportive of advancing clinical program - - Plans are underway to conduct Phase IIb trial following consultation with the FDA -Stemedica Cell Technol...
Read more https://view-release/?pr-id=76961